Summary of Key Points Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a slight increase, with a closing price of 5.95 yuan on August 1, 2025, reflecting a 2.76% rise, amidst mixed capital flows from different investor groups [1]. Financial Performance - Chuangye Huikang reported a main revenue of 290 million yuan in Q1 2025, a year-on-year decrease of 22.67% - The net profit attributable to shareholders was -15.64 million yuan, down 226.6% year-on-year - The company’s gross profit margin stands at 55.12% [4][5]. Capital Flow Analysis - On August 1, 2025, the net inflow of main funds was 18.34 million yuan, accounting for 3.04% of the total transaction amount - Retail investors experienced a net outflow of 16.92 million yuan, representing 2.8% of the total transaction amount [1][2]. Financing and Margin Trading - On August 1, 2025, the financing buy amounted to 48.18 million yuan, while the financing repayment was 65.73 million yuan, resulting in a net repayment of 17.55 million yuan - The total margin trading balance was 498 million yuan [1][2]. Industry Comparison - Chuangye Huikang's total market value is 9.171 billion yuan, compared to the software development industry average of 12.789 billion yuan - The company has a price-to-earnings ratio of -146.52, significantly lower than the industry average of 70.97 [4][5]. Institutional Ratings - In the last 90 days, three institutions have rated the stock, with two buy ratings and one hold rating - The average target price set by institutions is 6.13 yuan [5].

Core Viewpoint - The company, Chuangye Huikang, is focusing on innovation in the healthcare information technology sector, with significant investments in research and development aimed at enhancing its product offerings and operational efficiency [2][3]. Group 1: Company Performance - As of July 23, 2025, Chuangye Huikang's stock closed at 5.55 yuan, down 1.07%, with a turnover rate of 2.56%, a trading volume of 391,400 shares, and a transaction value of 219 million yuan [1]. - On the same day, the net outflow of funds from major investors was 18.81 million yuan, while retail investors saw a net inflow of 20.50 million yuan [4]. Group 2: Research and Development Focus - The company reported that its R&D investment accounted for 20-30% of its revenue, focusing on areas such as smart healthcare, regional health, and health city development [2]. - Key projects include the Hi-HIS clinical medical system, integrated grassroots health information systems, and a data governance platform [2]. - The company is actively integrating artificial intelligence into its operations, with products like Smart EMR and My Doctor being deployed in medical settings [2]. Group 3: Strategic Initiatives - The "Huikang Cloud" transformation strategy initiated in 2021 aims to migrate management and collaboration processes to the cloud, enhancing operational efficiency and resource sharing [2]. - The company is upgrading its low-code platform to reduce development complexity and implementation time for its core products, thereby improving the maturity and functionality of its Hi-HIS offerings [2].

Investment Rating - The report maintains a positive investment rating for the domestic computing power and AI application sectors, highlighting significant growth potential in these areas [6]. Core Insights - A new round of AI "arms race" has commenced globally, with the release of major models like Grok4 and Kimi K2 expected to significantly boost domestic computing power demand and application ecosystems [4][10]. - The report emphasizes the importance of focusing on domestic AI computing power, particularly in chip design, advanced wafer manufacturing, and liquid cooling technologies [4]. - Various AI application sectors are highlighted, including office automation, programming, terminal AI, ERP/CRM, judicial applications, financial/taxation services, education, healthcare, and customer service [4]. Summary by Sections Market Review - During the week of July 7-11, the CSI 300 index rose by 0.82%, the SME index increased by 0.73%, and the ChiNext index saw a rise of 2.36%. The computer sector (CITIC) experienced a growth of 3.37% [2]. Industry News - Notable company developments include Zhuoyi Information's plan to reduce its shareholding by up to 2,271,445 shares, representing no more than 1.88% of total shares [3]. - Wanjie Technology received nine invention patent certificates from the National Intellectual Property Administration [3]. Weekly Insights - The report suggests focusing on key players in the domestic AI computing power sector, such as Cambrian and Haiguang Information in chip design, and SMIC in advanced wafer manufacturing [4]. - The report also identifies various AI application companies across different sectors, including Kingsoft Office, Hehe Information, and Keda Xunfei in office automation and education [4]. Recent Developments - The report outlines significant investments and acquisitions in the AI sector, including Amazon's potential additional investment in Anthropic and Google's acquisition of AI programming startup Windsurf's core talent and technology [16][17]. - The report notes that xAI, led by Elon Musk, is negotiating a new funding round that could value the company at up to $200 billion, reflecting the growing interest and investment in AI technologies [10][18]. AI Application Ecosystem - The report highlights the rapid growth of AI applications, with OpenAI and Anthropic achieving annual recurring revenues (ARR) of $10 billion and $3 billion, respectively [22]. - Domestic AI applications like deepseek and Doubao are showing significant commercial potential, with user engagement metrics comparable to leading international AI applications [22]. Global AI Company Rankings - The report provides a ranking of global AI companies based on their ARR, with OpenAI leading at $10 billion, followed by Anthropic at $3.008 billion [23].

证券代码：300451 证券简称：创业慧康 公告编号：2025-039 创业慧康科技股份有限公司 关于持股5%以上股东减持股份预披露公告 1、减持原因：偿还债务及利息，降低质押融资风险。 持股 5% 以上股东葛航先生保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持股 5%以上股东葛航先生计划自公告之日起十五个交易日后的 3 个月内 （在此期间如遇法律、法规规定的窗口期则不减持）计划以集中竞价方式减持 不超过 9,294,748 股（含），占剔除回购专用账户股份数后公司总股本的 0.6018%。 创业慧康科技股份有限公司（以下简称"公司"、"本公司"）于近日收 到持股 5%以上股东葛航先生出具的《关于股份减持计划的告知函》，现将相关 事项公告如下： 一、股东的基本情况 1、股东的名称：葛航 2、股东持股情况：截至本公告日，葛航先生持有本公司 165,074,982 股， 占本公司总股本比例 10.66%，占剔除公司回购专用账户股份后总股本比例 10.69%。 二、本次减持计划的主要内容 2、股份来源：公 ...

Core Viewpoint - The digital hospital industry in China is experiencing rapid growth, with the market size expected to reach 487.7 billion yuan in 2024 and 525 billion yuan in 2025, driven by advancements in technology and the need for modernization in healthcare [1][4][6]. Digital Hospital Industry Definition and Classification - Digital hospitals utilize advanced computer network systems to integrate patient diagnosis, health economic information, and hospital management data into a comprehensive information management system [2][4]. - Key products in the digital hospital industry include Hospital Information Systems (HIS), Clinical Information Systems (CIS), Picture Archiving and Communication Systems (PACS), Laboratory Information Systems (LIS), and Electronic Medical Records (EMR) [2]. Current Development Status of the Digital Hospital Industry - The digital hospital market in China has grown from 18.2 billion yuan in 2014 to 487.7 billion yuan in 2024, with projections for 2025 indicating further growth [4][6]. - The digital transformation of hospitals is essential for adapting to societal changes and improving operational efficiency [4][6]. Industry Structure and Value Chain - The digital hospital industry value chain includes upstream technology and equipment suppliers, midstream solution integrators, and downstream hospitals [8]. - The application of digital solutions in hospitals is expanding, enhancing operational efficiency and service delivery [8]. Development Environment and Relevant Policies - The Chinese government has implemented various policies to support the digital transformation of hospitals, emphasizing the need for electronic medical records and health information sharing [10][12]. - Key policies include the promotion of smart hospitals and the integration of health information systems across regions [10][12]. Competitive Landscape of the Digital Hospital Industry - The market features both domestic and international players, with major companies including Microsoft, Cisco, IBM, and domestic firms like Eastsoft, Founder, Huawei, and others [13][15]. - Domestic companies are increasingly gaining market share, focusing on providing comprehensive digital solutions for hospitals [13][15]. Key Companies in the Digital Hospital Industry - Eastsoft has over 300 proprietary products and provides comprehensive information solutions for hospitals, with projected revenues of 13.32 billion yuan in 2024 [15]. - Chuangyue Huikang has implemented over 10,000 healthcare information projects and serves more than 7,000 clients, with revenues of 1.423 billion yuan in 2024 [17]. Implementation Pathways for Digital Transformation - The digital transformation of hospitals requires top-level design, scientific data management, and strengthening of academic disciplines to enhance information management capabilities [19][21][22]. - Emphasis on cross-disciplinary collaboration and talent development is crucial for achieving sustainable growth in hospital information management [22][23].

证券代码：300451 证券简称：创业慧康 公告编号：2025-037 创业慧康科技股份有限公司 关于持股5%以上股东协议转让股份完成过户登记的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、创业慧康科技股份有限公司（以下简称"公司"）股东葛航先生（以下 简称"出让方"或"甲方"）为归还股票质押融资，与锦福源（海南）私募基金 管理合伙企业（有限合伙）（作为锦福源长弓五号私募证券投资基金管理人）（以 下简称"乙方"或"锦福源长弓五号基金"）、国元证券股份有限公司（以下简 称"国元证券"、"质权人"或"丙方"）签署了《股份转让协议》，拟通过协 议转让方式进行股票质押式回购交易违约处置，以股份转让价款偿还其在国元证 券的部分股票质押融资债务。 2、本次协议转让股份不触及要约收购。公司无控股股东、无实际控制人， 对公司生产经营、公司治理等方面不会产生影响。 3、本次股份转让所得全部价款均系用于偿还国元证券债务，受让方将在取 得深交所确认文件并经中登深圳分公司初审通过当天全额支付给国元证券，同时， 受让方在受让股份后六个月内不得减持其所受让的股份。 4 ...

创业慧康科技股份有限公司 关于持股5%以上股东权益变动触及1%整数倍的公告 证券代码：300451 证券简称：创业慧康 公告编号：2025-038 | 股份种类 | | 减持股数（万股） 减持比例（%） | | | | --- | --- | --- | --- | --- | | 股 | A | 4,000 | | 2.59% | | 合 | 计 | 4,000 | | 2.59% | | 本次权益变动方式（可多选） | | 通过证券交易所的集中交易□ | | | | 通过证券交易所的大宗交易□ | | | | | | 其他☑（协议转让） | | | | | | 3.本次变动前后，投资者及其一致行动人拥有上市公司权益的股份情况 | | | | | | 股东 | 股份性质 | 本次变动前持有股份 | | 本次变动后持有股份 | | 股数(股) 名称 | | 占总股本比 | 股数(股) | 占总股本比 | | | | 例 | | 例 | | 205,074,982 葛航 | 合计持有股份 其中：无限售条 | 13.28% | 165,074,982 | 10.69% | | 205,074,982 件股份 | ...

证券代码：300451 证券简称：创业慧康 公告编号：2025-035 创业慧康科技股份有限公司 第八届董事会第十六次会议决议公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"或"本公司"）第八届董事 会第十六次会议的通知于 2025 年 6 月 16 日以邮件、电话等方式向各位董事发出， 会议于 2025 年 6 月 24 日在公司三楼会议室以现场与通讯相结合的方式召开。会 议应到董事 11 名，实到董事 11 名，公司部分监事、高级管理人员列席了会议。 会议的召开及表决符合《中华人民共和国公司法》《创业慧康科技股份有限公司 章程》等有关规定。 此次会议由董事长张吕峥先生主持，参会董事认真审议后，依照有关规定通 过以下几项决议： 一、审议通过了《关于聘任公司财务总监的议案》 表决结果：此项议案以 11 票赞同，0 票反对，0 票弃权，该议案获得通过。 二、审议通过了《关于制定<会计师事务所选聘制度（2025 年 6 月）>的议 案》 为进一步完善公司选聘会计师事务所的行为，切实维护股东利益，提高审计 工作和财务信息的 ...

创业慧康科技股份有限公司 会计师事务所选聘制度 二〇二五年六月 会计师事务所选聘制度 （四）提出拟选聘会计师事务所及审计费用的建议，提交决策机构决定； 第一章 总则 第一条 为规范创业慧康科技股份有限公司（以下简称"公司"）选聘（含 续聘、改聘，下同）会计师事务所的行为，切实维护股东利益，提高财务信息质 量，根据《国有企业、上市公司选聘会计师事务所管理办法》《创业慧康科技股 份有限公司章程》（以下简称"《公司章程》"）等相关要求，结合公司实际情 况，制定本制度。 第二条 公司选聘对公司财务会计报告、内部控制等发表审计意见、出具审 计报告的，需遵照本制度的规定。选聘其他专项审计业务的会计师事务所，公司 管理层视重要性程度可参照本制度执行。 第二章 职责权限 第三条 公司选聘会计师事务所应经董事会审计委员会（以下简称"审计委 员会"）审核后，报经董事会和股东大会审议。公司不得在董事会、股东大会审 议前聘请会计师事务所开展审计业务。 第四条 公司审计委员会负责选聘会计师事务所工作，并监督其审计工作开 展情况。审计委员会在选聘会计师事务所时应当切实履行下列职责： （一）按照董事会的授权制定选聘会计师事务所的政策、流程 ...

证券代码：300451 证券简称：创业慧康 公告编号：2025-036 创业慧康科技股份有限公司 关于聘任公司财务总监的公告 特此公告。 创业慧康科技股份有限公司 董事会 2025 年 6 月 24 日 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司(以下简称"公司")于 2024 年 9 月 30 日召开第 八届董事会第九次会议，审议通过了《关于董事会秘书代行财务总监职责的议案》， 在公司董事会聘任新的财务总监之前，将由董事会秘书胡燕女士代行公司财务总 监职责。 近日，根据《中华人民共和国公司法》《创业慧康科技股份有限公司章程》 及相关法律法规的规定，经公司总经理提名，并经公司第八届董事会提名委员会、 审计委员会审核通过，公司于 2025 年 6 月 24 日召开了第八届董事会第十六次会 议，审议通过了《关于聘任公司财务总监的议案》。同意聘任郑奇先生（简历详 见附件）为公司财务总监，自本次董事会审议通过之日起至第八届董事会任期届 满之日止。胡燕女士将不再代行公司财务总监职责，仍继续担任公司董事会秘书。 胡燕女士在代行公司财务总监期间勤勉 ...